🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 7

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Wed, Jun 4, 2025 at 3:50 AM 44 replies 2,251 viewsPage 7 of 9
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Jun 4, 2025 at 1:45 PM#31

Saving this for reference. Quality thread.

16 1amy_econ_NJ, bbq_ray_KC, oliver_london and 13 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Jun 4, 2025 at 2:02 PM#32

Subscribing to this thread. MASH prevalence in GLP-1 is exactly what I've been researching. 🙏

9 4roxy_nash, tony_orlando, Dr.NephBHM_UK and 6 others
Reply Quote Save Share Report
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Jun 4, 2025 at 2:19 PM#33

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on MASH prevalence in GLP-1.

To answer tampaLisa73: I started tracking everything in a spreadsheet from day 1.

Quick update: I will post a proper update thread soon. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

21 17sarah_nash92, FitDadDave, RunnerRach and 18 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Jun 4, 2025 at 2:36 PM#34

100%. My provider said the same thing about MASH prevalence in.

Last edited: Jun 4, 2025 at 3:36 PM
22 18lisa_labSD, adam_van, Dr.SurgeonPGH and 19 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Jun 4, 2025 at 2:53 PM#35

+1 to SallyK_inj. Especially the point about "Saving this for reference..." — I have seen the same in my own experience with MASH prevalence in GLP-1.

34 12ChrisMacros, KetoKyle, CanadaChris and 31 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register